Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Dr. Xuping Xie, University of Texas Medical Branch

NanoLuc® Luciferase Reporter Viruses

Dr. Xie’s group constructed a NanoLuc® SARS-CoV-2 reporter virus and screened a broad selection of existing anti-infective drugs. They identified several agents, including remdesivir, as potent, selective inhibitors of SARS-CoV-2. They also used the reporter virus to measure neutralizing antibody levels in COVID-19 patients.

Learn More

NanoLuc® Luciferase: One Enzyme, Endless Capabilities

Go to Technology Page

NanoLuc® Technologies Advance Virology Research

View Products